ANI Pharmaceuticals Stock (NASDAQ:ANIP)
Previous Close
$54.26
52W Range
$52.00 - $70.81
50D Avg
$57.85
200D Avg
$61.87
Market Cap
$1.12B
Avg Vol (3M)
$248.69K
Beta
0.71
Div Yield
-
ANIP Company Profile
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANIP Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Sales of generic pharmaceutical products | $269.45M | $210.12M | $143.57M |
| Sales of rare disease pharmaceutical products | $112.12M | $41.69M | - |
| Sales of established brand pharmaceutical products | $105.25M | $39.46M | - |
| Other | - | $693.00K | $1.86M |
| Product development services | - | $2.95M | $1.31M |
| Sales of contract manufactured products | - | $4.30M | $3.80M |
| Royalties from licensing agreements | - | $5.37M | $11.79M |
| Sales of branded pharmaceutical products | - | - | $47.56M |
Fiscal year ends in Dec 23 | Currency in USD
Peer Comparison
| Ticker | Company |
|---|---|
| PAHC | Phibro Animal Health Corporation |
| NBIX | Neurocrine Biosciences, Inc. |
| INCR | InterCure Ltd. |
| RDY | Dr. Reddy's Laboratories Limited |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| PROC | Procaps Group S.A. |
| PCRX | Pacira BioSciences, Inc. |
| PBH | Prestige Consumer Healthcare Inc. |
| ALKS | Alkermes plc |
| COLL | Collegium Pharmaceutical, Inc. |
| AMPH | Amphastar Pharmaceuticals, Inc. |